Pharma News Intelligence November 29, 2023
Veronica Salib

Among almost 30 other proposed plans, the Biden administration announced its intention to strengthen the pharmaceutical supply chain through the DPA.

On Monday, November 27, 2023, the White House released a fact sheet from the Biden administration outlining plans to strengthen domestic supply chains, reduce consumer costs, and secure key supply chain sectors. Amidst the many other supply chains mentioned, the administration announced its plans to bolster the pharmaceutical supply chain and minimize the number of national drug shortages.

One of the significant actions marked by the release of this fact sheet is the first meeting of the White House Council on Supply Chain Resilience, intended to support long-term, government-wide tools to stabilize supply chains. Alongside multiple other federal organizations,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Pharma, Pharma / Biotech, Supply Chain, Technology
Related Articles:
The AI Software Supply Chain Is A Dumpster Fire: Here's What Companies Can Do About It
Supply chain challenges in 2025: 5 things to know
As Supply Chains Go Digital, Cybersecurity Must be Strongest Link
Digital twins: The key to unlocking end-to-end supply chain growth
Why Supply Chain Technology Keeps Failing—And How To Fix It

Share This Article